IP Library Granted Patent US 8,535,388
Granted Patent B2
US 8,535,388 · App. 13/303,811 · Granted Sep 17, 2013

Bone graft

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,535,388
App. No.
13/303,811
Granted
Sep 17, 2013
Kind
B2
Abstract

The present invention relates to a novel bone graft and methods for producing said graft. Said bone graft can be used for surgical, plastic and/or cosmetic bone replacement for a patient in need thereof. The bone graft is made of a scaffold or matrix of sheet material having a 3-dimensional pattern of a continuous network of voids and/or indentations for enhancing new bone growth.

Claims (77)

1. A sheet material for a bone matrix scaffold, comprising a surface pattern that is enhancing osteo-conductivity, wherein the surface pattern is a 3-dimensional continuous network having voids or indentations, the surface pattern mimicking under-modeled cancellous bone of a marine or sea mammal; and wherein the bone pattern exhibits the following characteristics;

BIOPSY

BV/TV

BS/BV

TbTh

TbSp

TbN

Ost#

Cross

17.71

14.98

135.16

631.70

1.33

230/mm 2

Long

24.64

8.67

231.05

710.09

1.06

 150/mm 2 .

2. The sheet material according to claim 1 , wherein the sheet has a thickness of 150 microns to 2 mm.

3. The sheet material according to claim 1 , wherein the sheet consists essentially of collagen.

4. The sheet material according to claim 1 , wherein the voids have an average width in the range of 30 to 150 microns.

5. The sheet material according to claim 1 , wherein said material is essentially biodegradable, bioerodable and/or bioresorbable, and/or bioinstructive.

6. The bone matrix scaffold according to claim 1 , wherein the sheet material forms a macrostructure having a substantially continuous network and voids.

7. The bone matrix scaffold according to claim 6 , further comprising at least one or more additional sheets of material having the surface pattern mimicking under-modeled cancellous bone of a marine or sea mammal; and wherein the bone pattern exhibits the following characteristics;

BIOPSY

BV/TV

BS/BV

TbTh

TbSp

TbN

Ost#

Cross

17.71

14.98

135.16

631.70

1.33

230/mm 2

Long

24.64

8.67

231.05

710.09

1.06

 150/mm 2 .

8. The bone matrix scaffold according to claim 7 , comprising a laminate structure consisting of the at least one or more additional sheets of material and the sheet forming the macrostructure.

9. The bone matrix scaffold according to claim 6 , wherein said network is semi-solid, in particular forming a gel.

10. The bone matrix scaffold according to claim 6 , furthermore comprising crosslink-structures.

11. The bone matrix scaffold according to claim 10 , wherein said crosslink-structures comprise at least one polymer and/or a mixture of polymers.

12. The bone matrix scaffold according to claim 11 , wherein said at least one polymer is a copolymer having carboxylic acid groups and/or amine groups.

13. The bone matrix scaffold according to claim 11 , wherein said at least one polymer is a conductive polymer selected from polypyrrole, polyaniline, polyacetylene, and/or polythiophene.

14. The bone matrix scaffold according to claim 11 , wherein said crosslink-structures comprise collagen fibers.

15. The bone matrix scaffold according to claim 14 , wherein said crosslink-structures comprise non-aldehyde cross-linked type I collagen.

16. The bone matrix scaffold according to claim 14 , wherein said crosslink-structures form spokes and/or mimic cell microfilaments.

17. The bone matrix scaffold according to claim 14 , wherein said collagen is chemically cross-linked with nordihydroguaiaretic acid to confer stability.

18. The bone matrix scaffold according to claim 6 having a surface area of at least 1 m 2 /g.

19. The bone matrix scaffold according to claim 6 , wherein the voids of said sheet forming the macrostructure are continuous.

20. The bone matrix scaffold according to claim 8 , wherein at least 10% of said voids of said sheet forming the macrostructure and said voids of said one or more additional sheets of material are connected.

21. The bone matrix scaffold according to claim 6 , wherein said voids of said sheet forming said macrostructure and said voids of said additional sheets of material are not connected.

22. The bone matrix scaffold according to claim 6 , wherein said voids at the surface of said macrostructure define openings and the average diameter of said openings measured at the surface and the average diameter of the voids measured in a cross-section of the network of the macrostructure have a ratio of from 2:1 to 10:1.

23. The bone matrix scaffold according to claim 22 , wherein the ratio is from 2:1 to 5:1.

24. The bone matrix scaffold according to claim 6 , wherein the network of a cubic portion of said matrix has dimensions of 0.5 cm on all sides and voids defining openings with an average diameter of 50-800 μm, and at least 10% of the voids are connected.

25. The bone matrix scaffold according to claim 24 , wherein at least 20% of the voids are connected.

26. The bone matrix scaffold according to claim 6 , wherein a cross section of said network has a maximum and minimum diameter, with a ratio of the maximum and minimum diameter of from 1:1 to 10:1.

27. The bone matrix scaffold according to claim 6 , wherein the exterior surface of said scaffold is porous.

28. The bone matrix scaffold according to claim 27 , having a porosity of at least 20%.

29. The bone matrix scaffold according to claim 6 , wherein said bone matrix scaffold is essentially biodegradable, bioerodable and/or bioresorbable.

30. The bone matrix scaffold according to claim 6 , wherein the bone matrix scaffold is essentially permeable to body fluids and/or cells.

31. The bone matrix scaffold according to claim 6 , further comprising cells and/or proteins.

32. The bone matrix scaffold according to claim 31 , wherein said cells are selected from the group of living cells and recombinant cells, chondrocytes, growth factor producing cells, such as TGF-producing cells, and osteoblasts, and the proteins are selected from proteins that inhibit or enhance vascularization, enhance or retard innervation, attune or suppress inflammation accuate or impede cell proliferation.

33. The bone matrix scaffold according to claim 31 , wherein the size of said matrix scaffold changes less than 50% when said cells are added to the matrix.

34. The bone matrix scaffold according to claim 6 having a compressive modulus of at least 0.4 MPa at 4% strain.

35. The bone matrix scaffold according to claim 6 having a density of less than 0.150 g/cm 3 .

Assignments (15)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2021
From: GANEY, TIMOTHY
To: BONE PHARM, LLC
Reel/Frame 055780/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2020
From: VIVEX BIOMEDICAL, INC.
To: GANEY, TIMOTHY
Reel/Frame 053772/0339 →
RELEASE OF SECURITY INTEREST Recorded Dec 12, 2019
From: HERITAGE BANK OF COMMERCE
To: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
Reel/Frame 051282/0653 →
RELEASE OF SECURITY INTEREST Recorded Mar 28, 2017
From: SILICON VALLEY BANK
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 042103/0686 →
SECURITY INTEREST Recorded Feb 22, 2017
From: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC.; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 041782/0452 →
RELEASE OF SECURITY INTEREST Recorded Apr 29, 2016
From: SILICON VALLEY BANK, AS ADMINISTRATIVE AGENT
To: AMENDIA, INC.; OMNI ACQUISITION INC.
Reel/Frame 038578/0828 →
RELEASE OF SECURITY INTEREST Recorded Feb 3, 2016
From: ATLANTIC CAPITAL BANK
To: AMENDIA, INC.
Reel/Frame 037652/0714 →
SECURITY INTEREST Recorded Jan 5, 2016
From: VIVEX BIOMEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 037413/0089 →
RELEASE OF SECURITY INTEREST Recorded Sep 18, 2014
From: JPMORGAN CHASE BANK, N.A.
To: AMENDIA, INC.
Reel/Frame 033771/0759 →
PATENT SECURITY AGREEMENT Recorded Sep 9, 2014
From: AMENDIA, INC.; OMNI ACQUISITION, INC.
To: SILICON VALLEY BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 033696/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2014
From: AMENDIA, INC.
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 033629/0745 →
SECURITY INTEREST Recorded Jun 10, 2014
From: AMENDIA, INC.
To: JP MORGAN CHASE BANK NA
Reel/Frame 033120/0286 →
SECURITY AGREEMENT Recorded May 3, 2012
From: AMENDIA, INC.
To: MEDLINE INDUSTRIES, INC.
Reel/Frame 028148/0413 →
SECURITY AGREEMENT Recorded May 2, 2012
From: AMENDIA, INC.
To: ATLANTIC CAPITAL BANK
Reel/Frame 028141/0759 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2011
From: GANEY, TIMOTHY
To: AMENDIA, INC.
Reel/Frame 027275/0133 →